Medicare Enrolled
Dr. David Kim, M.D
Family Medicine · Smyrna, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. David Kim is a family medicine specialist in Smyrna, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 3,419 Medicare services across 1,614 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $7,146 from 54 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in GA
$7,146 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,419
Medicare services
Top 10% in GA for family medicine
1,614
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~171 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
708 | $87 | $181 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
398 | $36 | $79 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
396 | $36 | $99 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
378 | $30 | $59 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
263 | $129 | $188 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
224 | $1 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $55 | $124 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
114 | $9 | $95 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
82 | $87 | $150 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
75 | $3 | $36 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
60 | $84 | $381 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
60 | $37 | $50 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $10 | $29 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
41 | $261 | $850 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
41 | $17 | $40 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
41 | $22 | $75 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
35 | $165 | $286 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
26 | $32 | $55 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
26 | $31 | $42 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $56 | $191 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
23 | $218 | $280 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $43 | $145 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
19 | $79 | $191 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $47 | $99 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
17 | $3 | $29 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
16 | $54 | $95 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
15 | $27 | $46 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
12 | $60 | $224 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $97 | $316 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
17.4% medium
80.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,146
Total received (2018-2024)
Avg $1,021/year across 7 years
Top 9% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,140 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,206
2023
$1,309
2022
$1,567
2021
$966
2020
$561
2019
$651
2018
$886
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$399
Novo Nordisk Inc
$247
Lilly USA, LLC
$124
PFIZER INC.
$91
Bayer Healthcare Pharmaceuticals Inc.
$65
IDORSIA PHARMACEUTICALS US INC
$62
SHIELD THERAPEUTICS INC
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
GlaxoSmithKline, LLC.
$30
AstraZeneca Pharmaceuticals LP
$21
Dexcom, Inc.
$21
Sumitomo Pharma America, Inc.
$18
Abbott Laboratories
$17
Corcept Therapeutics
$15
Exact Sciences Corporation
$15
Amgen Inc.
$15
Top 3 companies account for 63.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,262
AstraZeneca Pharmaceuticals LP
$788
Lilly USA, LLC
$537
ABBVIE INC.
$488
Amgen Inc.
$381
PFIZER INC.
$329
GlaxoSmithKline, LLC.
$304
SANOFI-AVENTIS U.S. LLC
$282
IDORSIA PHARMACEUTICALS US INC
$207
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$187
Abbott Laboratories
$159
Eisai Inc.
$133
Novartis Pharmaceuticals Corporation
$126
Bayer HealthCare Pharmaceuticals Inc.
$126
Actelion Pharmaceuticals US, Inc.
$125
Shield Therapeutics Inc
$121
ARBOR PHARMACEUTICALS, INC.
$119
Bayer Healthcare Pharmaceuticals Inc.
$119
Biohaven Pharmaceutical Holding Company Ltd.
$104
Amarin Pharma Inc.
$83
Dexcom, Inc.
$81
Esperion Therapeutics, Inc.
$81
Coloplast Corp
$76
AbbVie Inc.
$76
Merck Sharp & Dohme Corporation
$72
Merck Sharp & Dohme LLC
$61
Exact Sciences Corporation
$60
Synergy Pharmaceuticals Inc
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Xeris Pharmaceuticals, Inc.
$48
Janssen Pharmaceuticals, Inc
$44
Allergan Inc.
$35
SHIELD THERAPEUTICS INC
$33
Biohaven Pharmaceuticals, Inc.
$31
Currax Pharmaceuticals LLC
$29
Bausch Health US, LLC
$27
Ultragenyx Pharmaceutical Inc.
$26
Circassia Pharmaceuticals Inc
$21
Edwards Lifesciences Corporation
$21
West-Ward Pharmaceuticals
$20
Teva Pharmaceuticals USA, Inc.
$19
Antares Pharma, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$19
Sumitomo Pharma America, Inc.
$18
Medtronic Vascular, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Corcept Therapeutics
$15
Mylan Specialty L.P.
$15
Arbor Pharmaceuticals, Inc.
$13
Boston Scientific Corporation
$13
DEXCOM, INC.
$12
Allergan, Inc.
$12
Genentech USA, Inc.
$12
Avion Pharmaceuticals
$11
Top 3 companies account for 36.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AJOVY · Aimovig · BASAGLAR · BELSOMRA · BOOSTRIX · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Balcoltra · Bidil · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · ClosureFast · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · MIGRANAL · MOUNJARO · Mitigare · NEXLETOL · NURTEC ODT · Otezla · Otrexup · Ozempic · PREVNAR 20 · Perforomist · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPRAVATO · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Titan · Tresiba · Trintellix · Trulance · UBRELVY · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6 · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
1,159
Per 100K population
150.7
County median income
$98,712
Nearest hospital
RIDGEVIEW INSTITUTE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 10% in GA), with low-engagement industry engagement in the top 9% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kim performed 708 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $7,146 from 54 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other family medicine physicians in Smyrna?
Dr. Kim's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Smyrna
Browse family medicine physicians in Smyrna ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology